Synairgen's Founders

Synairgen is
a respiratory drug development company with a particular focus
on lung antiviral defence in asthma, COPD and severe viral infections

Share price

Click above to open the London Stock Exchange website for the latest share price information

Latest report & accounts

Copies of our Report and Accounts can be found here

About us

Find out more about Synairgen, its Directors and Founders

Preliminary results for the year ended 31 December 2013 
20 March 2014  |  More

Holding in Company 
11 March 2014  |  More

Holding in Company 
06 March 2014  |  More


Licensing update, placing to raise £1.5 million and notice of results 
05 March 2014  |  More

Exercise of options 
14 October 2013  |  More

Interim results for the six months ended 30 June 2013 
12 August 2013  |  More


Synairgen plc

Registered in England and Wales No. 5233429



Registered office

Mailpoint 810, Level F, South Block,
Southampton General Hospital, Tremona Road,
Southampton, SO16 6YD, UK